Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 11, 2016 8:24 PM ET

Healthcare Equipment and Supplies

Company Overview of PharmaJet, Inc.

Company Overview

PharmaJet, Inc. develops and markets needle-free devices for the vaccine delivery market in United States and internationally. The company offers PharmaJet Stratis, a needle-free injector used to deliver medications and vaccines intramuscularly or subcutaneously by means of a fluid stream that penetrates the skin and delivers the medicine or vaccine to the tissue depth, as well as for delivery of an influenza vaccine and flu shots. Its needle-free injector is used for adults and children, and patients authorized by their physicians to self-inject, or to have others administer injections of prescribed medication. PharmaJet, Inc. was incorporated in 2005 and is based in Golden, Colorado.

400 Corporate Circle

Suite N

Golden, CO 80401

United States

Founded in 2005

Phone:

303-526-4278

Fax:

303-526-4052

Key Executives for PharmaJet, Inc.

Chairman and Chief Executive Officer
Age: 59
Chief Financial Officer
Chief Operating Officer
Chief Technology Officer
Vice Chairman and Chief Business Development Officer
Compensation as of Fiscal Year 2015.

PharmaJet, Inc. Key Developments

FDA Approves Use of AFLURIA Influenza Vaccine with PharmaJet, Inc.'s Needle-Free Injector

PharmaJet, Inc. announced the U.S. Food and Drug Administration (FDA) has approved the PharmaJet Stratis(R) 0.5mL Needle-Free Jet Injector for delivery of AFLURIA in individuals aged 18 to 64 years. This is the first needle-free delivery system approved by the FDA for the administration of an inactivated influenza vaccine. Needlestick injuries pose a serious risk to healthcare workers who administer vaccinations and manage sharps disposal. Among retail pharmacists alone, a National Institute for Occupational Safety and Health study reveals that the incidence of needlestick injury is up to 3.62 per 100,000 vaccinations administered. PharmaJet's needle-free injection technology eliminates needlestick injuries, needle re-use and potential cross contamination, as well as reduces sharps waste management and disposal costs.

Similar Private Companies By Industry

Company Name Region
Medtronic Xomed, Inc. United States
Aretech, LLC United States
Molnlycke Health Care US, LLC United States
MicroCor, Inc. United States
Shelhigh, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
June 3, 2015
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact PharmaJet, Inc., please visit www.pharmajet.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.